{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:26:05Z","timestamp":1788272765393,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFA0505801"],"award-info":[{"award-number":["2017YFA0505801"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2017CFA022"],"award-info":[{"award-number":["2017CFA022"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.vaccine.2021.05.093","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T21:40:42Z","timestamp":1623188442000},"page":"4135-4143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection"],"prefix":"10.1016","volume":"39","author":[{"given":"Jin","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zishu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.05.093_b0005","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.clindermatol.2014.12.011","article-title":"Update on hand-foot-and-mouth disease","volume":"33","author":"Ventarola","year":"2015","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.vaccine.2021.05.093_b0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7774\/cevr.2017.6.1.4","article-title":"Enterovirus 71 infection and vaccines","volume":"6","author":"Yi","year":"2017","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2021.05.093_b0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1743-422X-9-8","article-title":"Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications","volume":"9","author":"Xu","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2021.05.093_b0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.47102\/annals-acadmedsg.V38N2p106","article-title":"Epidemiology and control of hand, foot and mouth disease in Singapore, 2001\u20132007","volume":"38","author":"Ang","year":"2009","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.vaccine.2021.05.093_b0025","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/INF.0b013e3181a41d63","article-title":"Diseases caused by enterovirus 71 infection","volume":"28","author":"Lee","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2021.05.093_b0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.inf.0000115950.63906.78","article-title":"Fatal coxsackievirus A16 infection","volume":"23","author":"Wang","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2021.05.093_b0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.coviro.2012.02.009","article-title":"Recent advances in the molecular epidemiology and control of human enterovirus 71 infection","volume":"2","author":"McMinn","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2021.05.093_b0040","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41579-018-0005-4","article-title":"The life cycle of non-polio enteroviruses and how to target it","volume":"16","author":"Baggen","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2021.05.093_b0045","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.vaccine.2008.03.041","article-title":"Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection","volume":"26","author":"Chen","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.05.093_b0050","doi-asserted-by":"crossref","first-page":"498","DOI":"10.7150\/thno.7457","article-title":"Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop","volume":"4","author":"Xu","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.vaccine.2021.05.093_b0055","doi-asserted-by":"crossref","first-page":"e55517","DOI":"10.1371\/journal.pone.0055517","article-title":"Development of a sensitive and specific epitope-blocking ELISA for universal detection of antibodies to human enterovirus 71 strains","volume":"8","author":"He","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.05.093_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061256","article-title":"Advances in antigenic peptide-based vaccine and neutralizing antibodies against viruses causing hand, foot, and mouth disease","volume":"20","author":"Anasir","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2021.05.093_b0065","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.4161\/hv.28397","article-title":"Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial","volume":"10","author":"Chen","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.05.093_b0070","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.4161\/hv.28083","article-title":"Comparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line","volume":"10","author":"Yang","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.05.093_b0075","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1099\/vir.0.063560-0","article-title":"Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates","volume":"95","author":"Li","year":"2014","journal-title":"J General Virology"},{"key":"10.1016\/j.vaccine.2021.05.093_b0080","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.4161\/hv.29823","article-title":"Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice","volume":"10","author":"Sun","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.05.093_b0085","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4161\/hv.27087","article-title":"Coxsackievirus A16: epidemiology, diagnosis, and vaccine","volume":"10","author":"Mao","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.05.093_b0090","doi-asserted-by":"crossref","first-page":"e96051","DOI":"10.1371\/journal.pone.0096051","article-title":"Co-circulation and genomic recombination of coxsackievirus A16 and enterovirus 71 during a large outbreak of hand, foot, and mouth disease in Central China","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.05.093_b0095","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/1743-422X-8-508","article-title":"Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009","volume":"8","author":"Yang","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2021.05.093_b0100","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/cid\/ciu852","article-title":"Review of enterovirus 71 vaccines","volume":"60","author":"Chong","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.05.093_b0105","doi-asserted-by":"crossref","first-page":"e79783","DOI":"10.1371\/journal.pone.0079783","article-title":"Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers","volume":"8","author":"Chou","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.05.093_b0110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00430-016-0465-y","article-title":"Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy","volume":"205","author":"Aswathyraj","year":"2016","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2021.05.093_b0115","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1038\/emi.2016.73","article-title":"EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases","volume":"5","author":"Mao","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2021.05.093_b0120","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1586\/14760584.2015.993385","article-title":"EV71 vaccines: a first step towards multivalent hand, foot and mouth disease vaccines","volume":"14","author":"Klein","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2021.05.093_b0125","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1073\/pnas.1320624111","article-title":"Neutralizing antibodies can initiate genome release from human enterovirus 71","volume":"111","author":"Plevka","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2021.05.093_b0130","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.vaccine.2013.02.051","article-title":"Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16","volume":"31","author":"Shi","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.05.093_b0135","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nsmb.2255","article-title":"A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71","volume":"19","author":"Wang","year":"2012","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.vaccine.2021.05.093_b0140","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1128\/JVI.03029-13","article-title":"Human enterovirus 71 uncoating captured at atomic resolution","volume":"88","author":"Lyu","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.05.093_b0145","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1016\/j.vaccine.2011.04.010","article-title":"Identification and characterization of a cross-neutralization epitope of Enterovirus 71","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.05.093_b0150","doi-asserted-by":"crossref","first-page":"e49973","DOI":"10.1371\/journal.pone.0049973","article-title":"Immunological and biochemical characterization of coxsackie virus A16 viral particles","volume":"7","author":"Chong","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.05.093_b0155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","article-title":"Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development","volume":"31","author":"Kushnir","year":"2012","journal-title":"Vaccin"},{"key":"10.1016\/j.vaccine.2021.05.093_b0160","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/infdis\/jir474","article-title":"Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice","volume":"204","author":"Quan","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.05.093_b0165","first-page":"7878","article-title":"Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice","volume":"5","author":"Zhao","year":"2015","journal-title":"Sci Re"},{"key":"10.1016\/j.vaccine.2021.05.093_b0170","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1016\/j.vaccine.2012.08.071","article-title":"A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge","volume":"30","author":"Liu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.05.093_b0175","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.vaccine.2015.11.027","article-title":"Baculovirus vectors expressing F proteins in combination with virus-induced signaling adaptor (VISA) molecules confer protection against respiratory syncytial virus infection","volume":"34","author":"Zhang","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.05.093_b0180","doi-asserted-by":"crossref","first-page":"10099","DOI":"10.1073\/pnas.92.22.10099","article-title":"Efficient gene transfer into human hepatocytes by baculovirus vectors","volume":"92","author":"Hofmann","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2021.05.093_b0185","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/biot.201400438","article-title":"The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors","volume":"10","author":"Felberbaum","year":"2015","journal-title":"Biotechnol J"},{"key":"10.1016\/j.vaccine.2021.05.093_b0190","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1023\/A:1024071514438","article-title":"Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells","volume":"25","author":"Hu","year":"2003","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.vaccine.2021.05.093_b0195","doi-asserted-by":"crossref","first-page":"6444","DOI":"10.1128\/JVI.00200-14","article-title":"Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development","volume":"88","author":"Gong","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.05.093_b0200","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1016\/j.vaccine.2010.08.052","article-title":"Enterovirus 71 virus-like particle vaccine: Improved production conditions for enhanced yield","volume":"28","author":"Chung","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.05.093_b0205","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1016\/j.vaccine.2017.10.101","article-title":"Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice","volume":"35","author":"Huo","year":"2017","journal-title":"Vaccin"},{"key":"10.1016\/j.vaccine.2021.05.093_b0210","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.virol.2003.08.003","article-title":"Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection","volume":"316","author":"Yoshida","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2021.05.093_b0215","doi-asserted-by":"crossref","first-page":"8663","DOI":"10.1128\/JVI.78.16.8663-8672.2004","article-title":"Baculovirus vectors elicit antigen-specific immune responses in mice","volume":"78","author":"Facciabene","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.05.093_b0220","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.antiviral.2016.05.001","article-title":"Chimeric virus-like particles containing a conserved region of the G protein in combination with a single peptide of the M2 protein confer protection against respiratory syncytial virus infection","volume":"131","author":"Qiao","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2021.05.093_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/v12090906","article-title":"Two RSV platforms for G, F, or G+F proteins VLPs","volume":"12","author":"Ha","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2021.05.093_b0230","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1016\/j.vaccine.2017.03.065","article-title":"A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus","volume":"35","author":"Wu","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.05.093_b0235","first-page":"1","article-title":"Production and purification of virus-like particles of different enterovirus subtypes as vaccines","volume":"13","author":"Lin","year":"2017","journal-title":"J Taiwan Ins Chem Eng"},{"key":"10.1016\/j.vaccine.2021.05.093_b0240","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/14760584.2018.1510326","article-title":"Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease","volume":"17","author":"Fang","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2021.05.093_b0245","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.05.093_b0250","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1016\/j.vaccine.2014.06.025","article-title":"A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice","volume":"32","author":"Ku","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.05.093_b0255","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1016\/j.vaccine.2013.07.075","article-title":"Epitope engineering and molecular metrics of immunogenicity: a computational approach to VLP-based vaccine design","volume":"31","author":"Joshi","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.05.093_b0260","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13104-015-1780-x","article-title":"EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge","volume":"9","author":"Wang","year":"2016","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.vaccine.2021.05.093_b0265","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1016\/j.vaccine.2012.09.030","article-title":"Cross-reactive neutralizing antibody epitopes against Enterovirus 71 identified by an in silico approach","volume":"30","author":"Kirk","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.05.093_b0270","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/ncomms2889","article-title":"Picornavirus uncoating intermediate captured in atomic detail","volume":"4","author":"Ren","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2021.05.093_b0275","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1128\/JVI.00422-15","article-title":"Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71\/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease","volume":"89","author":"Lyu","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.05.093_b0280","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1128\/JVI.01848-13","article-title":"Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms","volume":"88","author":"Ye","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.05.093_b0285","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1586\/14760584.2016.1138862","article-title":"EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD)","volume":"15","author":"Mao","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2021.05.093_b0290","doi-asserted-by":"crossref","first-page":"e64024","DOI":"10.1371\/journal.pone.0064024","article-title":"Human IgG subclasses against enterovirus Type 71: neutralization versus antibody dependent enhancement of infection","volume":"8","author":"Cao","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.05.093_b0295","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00430-013-0289-y","article-title":"Subneutralizing antibodies to enterovirus 71 induce antibody-dependent enhancement of infection in newborn mice","volume":"202","author":"Chen","year":"2013","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2021.05.093_b0300","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1570162X113116660062","article-title":"Antibody-dependent enhancement and the risk of HIV infection","volume":"11","author":"Gorlani","year":"2013","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.vaccine.2021.05.093_b0305","doi-asserted-by":"crossref","first-page":"9273241","DOI":"10.1155\/2020\/9273241","article-title":"Predicting severe enterovirus 71-infected hand, foot, and mouth disease: cytokines and chemokines","volume":"2020","author":"Zhang","year":"2020","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.vaccine.2021.05.093_b0310","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1203\/01.pdr.0000238247.86041.19","article-title":"Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71","volume":"60","author":"Chang","year":"2006","journal-title":"Pediatr Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21007015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21007015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:57:59Z","timestamp":1759402679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21007015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":62,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0264410X21007015"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.093","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}